Eden Research (EDEN)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 0.000p
   
  • Closing Price Chg:
      0.000p
  • 52 Week High: 4.00p
  • 52 Week Low: 2.00p
  • Currency: UK Pounds
  • Shares Issued: 533.35m
  • Volume: 0
  • Beta: 0.01

Other News

No recent information was found.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Eden Research Market Data

Currency UK Pounds
Share Price 3.00p
Closing Price Change 0.000p
% Change 0.00 %
52 Week High 4.00p
52 Week Low 2.00p
Volume 0
Shares Issued 533.35m
Beta 0.01

Eden Research Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
10.18% below the market average10.18% below the market average10.18% below the market average10.18% below the market average10.18% below the market average
17.07% below the sector average17.07% below the sector average17.07% below the sector average17.07% below the sector average17.07% below the sector average
Price Trend
56.69% below the market average56.69% below the market average56.69% below the market average56.69% below the market average56.69% below the market average
22.73% below the sector average22.73% below the sector average22.73% below the sector average22.73% below the sector average22.73% below the sector average
Income Not Available
Growth
55.15% above the market average55.15% above the market average55.15% above the market average55.15% above the market average55.15% above the market average
58.62% above the sector average58.62% above the sector average58.62% above the sector average58.62% above the sector average58.62% above the sector average

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 1
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Eden Research Dividends

No dividends found

Trades for --2025

Time Volume / Share Price
0 @ 0.000p

Eden Research Key Personnel

CFO Alexander John Abrey
CEO Sean M. Smith

Top of Page